Clinical Characteristics of Patients Responding to Once-Daily Basal Insulin Therapy in Korean Subjects with Type 2 Diabetes
| Autor: | Dae Wook Lee, Sun Ok Song, Kyu Jeung Ahn, Young Duk Song, Byung Wan Lee, You-Cheol Hwang, Bong Soo Cha |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2015 |
| Předmět: |
medicine.medical_specialty
Evening endocrine system diseases Endocrinology Diabetes and Metabolism medicine.medical_treatment Type 2 diabetes Bioinformatics chemistry.chemical_compound Diabetes mellitus Internal medicine A1chieve® study Internal Medicine medicine Morning Original Research Korea business.industry Insulin Basal insulin responder medicine.disease Postprandial chemistry Metabolic control analysis Glycated hemoglobin business Detemir |
| Zdroj: | Diabetes Therapy |
| ISSN: | 1869-6961 1869-6953 |
| Popis: | Introduction A1chieve® (ClinicalTrials.gov identifier NCT00869908) was a 24-week observational study evaluating certain insulin analogs and not insulin analogs in general in 66,726 people with type 2 diabetes (T2D) in routine clinical care in 28 non-Western countries. This study demonstrated that insulin analogs improved self-management and metabolic control in patients with T2D. We investigated the effectiveness and clinical characteristics of patients with T2D showing better response to basal insulin (BI) (detemir), using data from the A1chieve study performed in Korea. Methods Subjects were classified into two groups according to the achievement of target glycated hemoglobin (A1c) level of |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink